Detalhe da pesquisa
1.
Lessons learned: new insights on the role of cytokines in COVID-19.
Nat Immunol
; 22(4): 404-411, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33723418
2.
The dynamic changes in cytokine responses in COVID-19: a snapshot of the current state of knowledge.
Nat Immunol
; 21(10): 1146-1151, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32855555
3.
Identification of a potent regulatory T cell epitope in factor V that modulates CD4+ and CD8+ memory T cell responses.
Clin Immunol
; 224: 108661, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33412295
4.
Transforming the clinical outcome in CRIM-negative infantile Pompe disease identified via newborn screening: the benefits of early treatment with enzyme replacement therapy and immune tolerance induction.
Genet Med
; 23(5): 845-855, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33495531
5.
The potential impact of timing of IVIG administration on the efficacy of rituximab for immune tolerance induction for patients with Pompe disease.
Clin Immunol
; 219: 108541, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32681978
6.
Novel reference genes in colorectal cancer identify a distinct subset of high stage tumors and their associated histologically normal colonic tissues.
BMC Med Genet
; 20(1): 138, 2019 08 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31409279
7.
CRIM-negative infantile Pompe disease: characterization of immune responses in patients treated with ERT monotherapy.
Genet Med
; 17(11): 912-8, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25741864
8.
A novel function of RNAs arising from the long terminal repeat of human endogenous retrovirus 9 in cell cycle arrest.
J Virol
; 87(1): 25-36, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23097441
9.
In silico methods for immunogenicity risk assessment and human homology screening for therapeutic antibodies.
MAbs
; 16(1): 2333729, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38536724
10.
Bortezomib in the rapid reduction of high sustained antibody titers in disorders treated with therapeutic protein: lessons learned from Pompe disease.
Genet Med
; 15(2): 123-31, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23060045
11.
Apolipoprotein B binding domains: evidence that they are cell-penetrating peptides that efficiently deliver antigenic peptide for cross-presentation of cytotoxic T cells.
J Immunol
; 186(8): 5004-11, 2011 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21402897
12.
Immunophenotype associated with high sustained antibody titers against enzyme replacement therapy in infantile-onset Pompe disease.
Front Immunol
; 14: 1301912, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38250073
13.
The role of immune tolerance induction in restoration of the efficacy of ERT in Pompe disease.
Am J Med Genet C Semin Med Genet
; 160C(1): 30-9, 2012 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22253234
14.
Response to de Vries et al.
Genet Med
; 19(11): 1281-1282, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28492534
15.
Successful immune tolerance induction to enzyme replacement therapy in CRIM-negative infantile Pompe disease.
Genet Med
; 14(1): 135-42, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22237443
16.
Persistence of high sustained antibodies to enzyme replacement therapy despite extensive immunomodulatory therapy in an infant with Pompe disease: need for agents to target antibody-secreting plasma cells.
Mol Genet Metab
; 105(4): 677-80, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22365055
17.
In silico Immunogenicity Assessment for Sequences Containing Unnatural Amino Acids: A Method Using Existing in silico Algorithm Infrastructure and a Vision for Future Enhancements.
Front Drug Discov (Lausanne)
; 22022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36945694
18.
Toxicity of high-molecular-weight polyethylene glycols in Sprague Dawley rats.
Toxicol Lett
; 359: 22-30, 2022 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35092809
19.
The impact of antibodies on clinical outcomes in diseases treated with therapeutic protein: lessons learned from infantile Pompe disease.
Genet Med
; 13(8): 729-36, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21637107
20.
Atypical immunologic response in a patient with CRIM-negative Pompe disease.
Mol Genet Metab
; 104(4): 583-6, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21889385